Boehringer May Face More Sanctions In Pradaxa MDL

Law360, New York (December 19, 2013, 6:15 PM EST) -- A week after hitting Boehringer Ingelheim International GmbH with a nearly $1 million penalty for discovery abuses, an Illinois federal judge ruled Wednesday that the drugmaker may be slapped with even more sanctions in multidistrict litigation over its blood thinner Pradaxa.

BII, the German parent of fellow defendant Boehringer Ingelheim Pharmaceuticals Inc., informed U.S. District Judge David Herndon on Monday that it has access to the so-called user share for a former employee, Thorstein Lehr, even though it had previously said the file was unavailable. In...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.